Skip to main content
SpringerLink
Log in

Infertilités endocriniennes féminines en dehors du syndrome des ovaires polykystiques

  • Chapter
Physiologie, pathologie et thérapie de la reproduction chez l’humain

  • 905 Accesses

Résumé

Les causes endocriniennes en dehors du syndrome des ovaires polykystiques représentent une relativement faible proportion des causes d’infertilité féminine. Elles rentrent dans le cadre des troubles ovulatoires, qui correspondent à 30% des causes féminines d’infertilité. Cependant, parmi ces dysovulations, la plus grande part est en relation avec un syndrome des ovaires polykystiques dont la fréquence dans la population générale est évaluée de 4 à 26% selon la population étudiée et les critères diagnostiques utilisés (1). Parmi les femmes ayant une infertilité d’origine endocrine, il représente 80% des cas (2).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) (2004) Human reproduction (Oxford, England) 19:41–47

    Google Scholar 

  2. Jonard S, Dewailly D (2001) Actualités sur le syndrome des ovaires polykystiques. Immunoanalyse & Biologie Spécialisée 16:302–305

    Article  Google Scholar 

  3. Edwards RG, Lobo R, Bouchard P (1996) Time to revolutionize ovarian stimulation. Human reproduction (Oxford, England) 11:917–919

    CAS  Google Scholar 

  4. ANAES (1996) Stérilité du couple. Recommandations et références médicales. wwwanaesfr

    Google Scholar 

  5. Schwartz JL, Creinin MD, Pymar HC et al. (2002) Predicting risk of ovulation in new start oral contraceptive users. Obstet Gynecol 99:177–182

    Article  PubMed  Google Scholar 

  6. Landgren BM, Unden AL, Diczfalusy E (1980) Hormonal profile of the cycle in 68 normally menstruating women. Acta Endocrinol 94:89–98

    PubMed  CAS  Google Scholar 

  7. Bukulmez O, Arici A (2004) Luteal phase defect: myth or reality. Obstetrics and Gynecol Clin North Am 31:727–744

    Article  Google Scholar 

  8. Young J, Tardy V, Brac de la Perrière A et al. (2010) French Society of Endocrinology — 2008 Consensus: Detection and Management of Late-Onset 21-Hydroxylase Deficiency in Women with Hyperandrogenism. Ann Endocrinol 71:14–18

    Article  CAS  Google Scholar 

  9. Zorn JR (2006) Place actuelle du test de Hühner dans l’exploration de la stérilité conjugale. Gynécologie Obstétrique & Fertilité 34:142–146

    Article  Google Scholar 

  10. Caron P, Chauvin S, Christin-Maitre S et al. (1999) Resistance of hypogonadic patients with mutated GnRH receptor genes to pulsatile GnRH administration. The Journal of clinical endocrinology and metabolism 84:990–996

    Article  PubMed  CAS  Google Scholar 

  11. Mohamed KA, Davies WA, Lashen H (2006) Antimullerian hormone and pituitary gland activity after prolonged down-regulation with goserelin acetate. Fertil Steril 86:1515–1517

    Article  PubMed  CAS  Google Scholar 

  12. Streuli I, Fraisse T, Pillet C et al. (2008) Serum antimullerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids. Fertil Steril 90:395–400

    Article  PubMed  CAS  Google Scholar 

  13. La Marca A, Giulini S, Orvieto R et al. (2005) Anti-Mullerian hormone concentrations in maternal serum during pregnancy. Human reproduction (Oxford, England) 20:1569–1572

    Article  Google Scholar 

  14. Fraisse T, Ibecheole V, Streuli I et al. (2008) Undetectable serum anti-Mullerian hormone levels and occurrence of ongoing pregnancy. Fertil Steril 89:723–729

    Article  PubMed  Google Scholar 

  15. Younis JS, Jadaon J, Izhaki I et al. (2010) A simple multivariate score could predict ovarian reserve, as well as pregnancy rate, in infertile women. Fertil Steril 94:655–661

    Article  PubMed  Google Scholar 

  16. Levy T, Orvieto R, Homburg R et al. (1996) Severe ovarian hyperstimulation syndrome despite low plasma oestrogen concentrations in a hypogonadotrophic, hypogonadal patient. Human reproduction (Oxford, England) 11:1177–1179

    CAS  Google Scholar 

  17. Salihu HM, Lynch ON, Alio AP et al. (2009) Extreme maternal underweight and feto-infant morbidity outcomes: a population-based study. J Maternal-Fetal & Neonatal Med 22:428–434

    Article  Google Scholar 

  18. Pizzi C, Evans SA, De Stavola BL et al. (2008) Lifestyle of UK commercial aircrews relative to air traffic controllers and the general population. Aviation, space, & Environ Med 79:964–974

    Article  Google Scholar 

  19. Dode C, Hardelin JP (2009) Kallmann syndrome. Eur J Hum Genet 17:139–146

    Article  PubMed  CAS  Google Scholar 

  20. Bringer J, Boulet F, Clouet S et al. (1990) Pulsatile administration of gonadotropin releasing hormone in the female. Diagnostic and therapeutic indications. Presse Med 19:1276–1281

    PubMed  CAS  Google Scholar 

  21. Christin-Maitre S, de Crecy M (2007) Pregnancy outcomes following pulsatile GnRH treatment: results of a large multicenter retrospective study. J Gynecol Obstet Biol Reprod (Paris) 36:8–12

    Article  CAS  Google Scholar 

  22. Martin K, Hall J, Adams J et al. (1993) Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea. J Clin Endocrinol Metab 77:125–129

    Article  PubMed  CAS  Google Scholar 

  23. The European Recombinant Human LH Study Group (1998) Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH-and FSH-deficient anovulatory women: a dose-finding study. J Clin Endocrinol Metab 83:1507–1514

    Article  Google Scholar 

  24. Tsilchorozidou T, Conway GS (2004) Uterus size and ovarian morphology in women with isolated growth hormone deficiency, hypogonadotrophic hypogonadism and hypopituitarism. Clinical Endocrinology 61:567–572

    Article  PubMed  Google Scholar 

  25. de Muinck Keizer-Schrama SM (2007) Introduction and management of puberty in girls. Horm Res 68 Suppl 5:80–83

    Article  Google Scholar 

  26. Campo S, Campo V, Lanzone A (2002) Twin pregnancy using recombinant gonadotropins in a woman with hypogonadotropic hypogonadism. Gynecol Endocrinol 16:27–32

    PubMed  CAS  Google Scholar 

  27. Brue T, Delemer B (2007) Diagnosis and management of hyperprolactinemia: expert consensus — French Society of Endocrinology. Ann Endocrinol (Paris) 68:58–64

    Article  CAS  Google Scholar 

  28. Bonneville JF, Bonneville F, Cattin F (2005) L’IRM hypophysaire: indications et résultats en gynécologie et en obstétrique. Gynécol Obst & Fertil 33:147–153

    Article  Google Scholar 

  29. Abalovich M, Amino N, Barbour LA et al. (2007) Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism 92:S1–S47

    Article  PubMed  CAS  Google Scholar 

  30. HAS (2007) Hypothyroïdies frustes chez l’adulte: diagnostic et prise en charge. www.has-santefr

  31. Gibney J, Smith TP, McKenna TJ (2005) Clinical relevance of macroprolactin. Clin Endocrinol (Oxf) 62:633–643

    Article  CAS  Google Scholar 

  32. Carranza-Lira S, González-Sánchez JL, Martínez-Chequer JC (1999) Vaginal bromocriptine administration in patients with hyperprolactinemia. Intern J Gynecol & Obstet 65:77–78

    Article  CAS  Google Scholar 

  33. Darwish AM, Farah E, Gadallah WA et al. (2007) Superiority of Newly Developed Vaginal Suppositories Over Vaginal Use of Commercial Bromocriptine Tablets: A Randomized Controlled Clinical Trial. Reproductive Sciences 14:280–285

    Article  PubMed  CAS  Google Scholar 

  34. Mendes MC, Ferriani RA, Sala MM et al. (2001) Effect of transitory hyperprolactinemia on in vitro fertilization of human oocytes. J Reprod Med 46:50

    Google Scholar 

  35. Nelson LM (2009) Clinical practice. Primary ovarian insufficiency. N Engl J Med 360:606–614

    Article  PubMed  CAS  Google Scholar 

  36. Bianco B, Lipay M, Guedes A et al. (2009) SRY gene increases the risk of developing gonadoblastoma and/or nontumoral gonadal lesions in Turner syndrome. Int J Gynecol Pathol 28:197–202

    Article  PubMed  Google Scholar 

  37. Agence de Biomedecine/CNGOF (2009) Syndrome de Turner et grossesse.http://wwwcngofassofr/D_PAGES/ACCUFRSTHTM

  38. Boissonnas CC, Davy C, Bornes M et al. (2009) Careful cardiovascular screening and follow-up of women with Turner syndrome before and during pregnancy is necessary to prevent maternal mortality. Fertil &d Steril 91:929.e925–929.e927

    Google Scholar 

  39. Pembrey ME, Barnicoat AJ, Carmichael B et al. (2001) An assessment of screening strategies for fragile X syndrome in the UK. Health Technol Assess 5:1–95

    PubMed  CAS  Google Scholar 

  40. Leite-Silva P, Bedone A, Pinto-Neto AM et al. (2009) Factors associated with bone density in young women with karyotypically normal spontaneous premature ovarian failure. Arch Gynecol Obstet 280:177–181

    Article  PubMed  Google Scholar 

  41. Uygur D, Sengul O, Bayar D et al. (2005) Bone loss in young women with premature ovarian failure. Arch Gynecol Obstet 273:17–19

    Article  PubMed  Google Scholar 

  42. Falhammar H, Thoren M, Hagenfeldt K (2008) A 31-year-old woman with infertility and polycystic ovaries diagnosed with non-classic congenital adrenal hyperplasia due to a novel CYP21 mutation. J Endocrinol Invest 31:176–180

    PubMed  CAS  Google Scholar 

  43. Nimkarn S, New MI (2009) Prenatal diagnosis and treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Mol Cell Endocrinol 300:192–196

    Article  PubMed  CAS  Google Scholar 

  44. Bachelot A, Chakhtoura Z, Rouxel A et al. (2007) Hormonal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Ann Endocrinol (Paris) 68:274–280

    CAS  Google Scholar 

  45. Bachelot A, Plu-Bureau G, Thibaud E et al. (2007) Long-term outcome of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res 67:268–276

    Article  PubMed  CAS  Google Scholar 

  46. Cohen MA, Sauer MV, Lindheim SR (1999) 21-hydroxylase deficiency and Turner’s syndrome: a reason for diminished endometrial receptivity. Fertil & Steril 72:937–939

    Article  CAS  Google Scholar 

  47. Haddow JE, Palomaki GE, Allan WC et al. (1999) Maternal Thyroid Deficiency during Pregnancy and Subsequent Neuropsychological Development of the Child. N Engl J Med 341:549–555

    Article  PubMed  CAS  Google Scholar 

  48. Carp HJ, Meroni PL, Shoenfeld Y (2008) Autoantibodies as predictors of pregnancy complications. Rheumatology (Oxford, England) 47 Suppl 3:iii6–iii8

    Article  Google Scholar 

  49. Alexander EK, Marqusee E, Lawrence J et al. (2004) Timing and Magnitude of Increases in Levothyroxine Requirements during Pregnancy in Women with Hypothyroidism. N Engl J Med 351:241–249

    Article  PubMed  CAS  Google Scholar 

  50. Laurberg P, Wallin G, Tallstedt L et al. (2008) TSH-receptor autoimmunity in Graves’ disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. Eur J Endocrinol 158:69–75

    Article  PubMed  CAS  Google Scholar 

  51. Dimitriadis E, White CA, Jones RL et al. (2005) Cytokines, chemokines and growth factors in endometrium related to implantation. Human Reprod Updates 11:613–630

    Article  CAS  Google Scholar 

  52. Henson MC, Castracane VD (2006) Leptin in Pregnancy: An Update. Biol Reprod 74:218–229

    Article  PubMed  CAS  Google Scholar 

  53. Giachini FRC, Carriel V, Capelo LP et al. (2008) Maternal diabetes affects specific extracellular matrix components during placentation. J Anat 212:31–41

    Article  PubMed  CAS  Google Scholar 

  54. Galettis A, Campbell S, Morris JM et al. (2004) Monocyte Adhesion to Decidual Endothelial Cells Is Increased in Pregnancies Complicated by Type 1 Diabetes but not by Gestational Diabetes. Diabetes Care 27:2514–2515

    Article  PubMed  Google Scholar 

  55. Lejeune V (2006) Fausses couches spontanées précoces répétées: quelle prise en charge proposer en 2006 ? Gynécol Obst & Fertil 34:927–937

    Article  CAS  Google Scholar 

  56. Jensen DM, Korsholm L, Ovesen P et al. (2009) Peri-conceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes. Diabetes Care 32:1046–1048

    Article  PubMed  Google Scholar 

  57. Langer O (2007) Oral anti-hyperglycemic agents for the management of gestational diabetes mellitus. Obstet Gynecol Clin North Am 34:255–274, ix

    Article  PubMed  Google Scholar 

  58. Nicholson W, Bolen S, Witkop CT et al. (2009) Benefits and risks of oral diabetes agents compared with insulin in women with gestational diabetes: a systematic review. Obstet Gynecol 113:193–205

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. MCU-PH Endocrinologie, UPMC Université, Paris 06

    N. Chabbert-Buffet

  2. Service de gynécologie obstétrique médecine de la reproduction, Hôpital Tenon, 4, rue de la Chine, 75020, Paris

    N. Chabbert-Buffet

Authors
  1. N. Chabbert-Buffet
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Chabbert-Buffet, N. (2011). Infertilités endocriniennes féminines en dehors du syndrome des ovaires polykystiques. In: Physiologie, pathologie et thérapie de la reproduction chez l’humain. Springer, Paris. https://doi.org/10.1007/978-2-8178-0061-5_16

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0061-5_16

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0060-8

  • Online ISBN: 978-2-8178-0061-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation